Evommune, Inc. · NYSE:EVMN
T. Rowe Price Associates Inc reported a 5.40% stake in Evommune, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
T. Rowe Price Associates Inc reported a 5.40% stake in Evommune, Inc., 1,940,939 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 1,940,939
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 5.40% | 1,940,939 |